• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Creating political commitment for antimicrobial resistance in developing countries.在发展中国家为抗微生物药物耐药性问题争取政治支持。
Indian J Med Res. 2019 Feb;149(2):83-86. doi: 10.4103/ijmr.IJMR_1980_17.
2
Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.利用“智能监管”应对低收入和中等收入国家的抗菌药物耐药性问题。
BMJ Glob Health. 2020 Jan 30;5(1):e001864. doi: 10.1136/bmjgh-2019-001864. eCollection 2020.
3
WHO Global Antimicrobial Resistance Surveillance System early implementation 2016-17.世界卫生组织全球抗菌药物耐药性监测系统2016 - 2017年早期实施情况
Lancet Infect Dis. 2018 Mar;18(3):241-242. doi: 10.1016/S1473-3099(18)30060-4. Epub 2018 Jan 29.
4
Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries.全球抗菌药物管理：关注中低收入国家
Int J Infect Dis. 2020 Jul;96:621-629. doi: 10.1016/j.ijid.2020.05.126. Epub 2020 Jun 4.
5
Strengthening surveillance key to addressing antimicrobial resistance.加强监测是应对抗菌药物耐药性的关键。
Indian J Med Microbiol. 2016 Oct-Dec;34(4):413-415. doi: 10.4103/0255-0857.195378.
6
Antimicrobial resistance: action by laboratories today for a cure tomorrow.抗微生物药物耐药性：今日实验室采取行动，明日实现治愈。
Indian J Med Microbiol. 2011 Jul-Sep;29(3):205-6. doi: 10.4103/0255-0857.83899.
7
Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives.资源有限国家的抗菌药物耐药性：独特挑战与有限选择
Semin Pediatr Infect Dis. 2004 Apr;15(2):94-8. doi: 10.1053/j.spid.2004.01.012.
8
Antimicrobial resistance--a 'rising tide' of national (and international) risk.抗菌药物耐药性——国家（及国际）层面风险的“上升浪潮”
J Hosp Infect. 2016 Jan;92(1):3-4. doi: 10.1016/j.jhin.2015.10.005. Epub 2015 Oct 24.
9
Emerging antimicrobial-resistant infections.新出现的耐药性感染
Arch Neurol. 2004 Oct;61(10):1512-4. doi: 10.1001/archneur.61.10.1512.
10
Antimicrobial resistance determinants and future control.抗菌药物耐药性决定因素与未来防控
Emerg Infect Dis. 2005 Jun;11(6):794-801. doi: 10.3201/eid1106.050167.

引用本文的文献

1
The Implementation of Antimicrobial Consumption Surveillance and Stewardship in Human Healthcare in Post-Soviet States: A Systematic Review.后苏联国家人类医疗保健中抗菌药物消费监测与管理的实施：一项系统综述
Antibiotics (Basel). 2025 Jul 25;14(8):749. doi: 10.3390/antibiotics14080749.
2
Mitigating inequitable access to appropriate antibiotics in low- and middle-income countries.缓解低收入和中等收入国家在获取适当抗生素方面的不平等现象。
JAC Antimicrob Resist. 2025 Apr 24;7(2):dlaf061. doi: 10.1093/jacamr/dlaf061. eCollection 2025 Apr.
3
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.政策企业家在中低收入国家遏制抗菌药物耐药性的努力中不可或缺。
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
4
Drivers of inappropriate antibiotic use in low- and middle-income countries.低收入和中等收入国家不适当使用抗生素的驱动因素。
JAC Antimicrob Resist. 2023 May 31;5(3):dlad062. doi: 10.1093/jacamr/dlad062. eCollection 2023 Jun.
5
Taking stock of global commitments on antimicrobial resistance.评估全球对抗微生物药物耐药性的承诺。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2021-008159.
6
Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions.后 COVID-19 时代耐碳青霉烯类革兰氏阴性菌流行趋势及抗菌药物使用分析：医疗机构面临的额外挑战。
J Hosp Infect. 2022 Feb;120:43-47. doi: 10.1016/j.jhin.2021.11.011. Epub 2021 Nov 19.
7
Policy actors and human and animal health practitioners' perceptions of antimicrobial use and resistance in Tanzania: A qualitative study.坦桑尼亚政策制定者以及人类和动物健康从业者对抗菌药物使用及耐药性的认知：一项定性研究
J Glob Antimicrob Resist. 2021 Jun;25:40-47. doi: 10.1016/j.jgar.2021.02.027. Epub 2021 Mar 1.
8
Antimicrobial Stewardship Programs in Resource Constrained Environments: Understanding and Addressing the Need of the Systems.资源受限环境中的抗菌药物管理计划：了解和满足系统需求。
Front Public Health. 2020 Apr 28;8:140. doi: 10.3389/fpubh.2020.00140. eCollection 2020.
9
Antibiotics without Prescriptions: US & Indian Perspective.无处方抗生素：美国与印度视角
Indian J Pediatr. 2020 Jan;87(1):36-38. doi: 10.1007/s12098-019-03122-z. Epub 2019 Dec 6.

本文引用的文献

1
Universal health coverage framework to combat antimicrobial resistance.抗击抗微生物药物耐药性的全民健康覆盖框架
Indian J Med Res. 2018 Mar;147(3):228-232. doi: 10.4103/ijmr.IJMR_1462_17.
2
Access to effective antimicrobials: a worldwide challenge.获取有效的抗菌药物：全球性挑战。
Lancet. 2016 Jan 9;387(10014):168-75. doi: 10.1016/S0140-6736(15)00474-2. Epub 2015 Nov 18.
3
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.中国动物和人类中出现的质粒介导的粘菌素耐药机制 MCR-1：微生物学和分子生物学研究。
Lancet Infect Dis. 2016 Feb;16(2):161-8. doi: 10.1016/S1473-3099(15)00424-7. Epub 2015 Nov 19.
4
Origins and evolution of antibiotic resistance.抗生素耐药性的起源与演变。
Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33. doi: 10.1128/MMBR.00016-10.

Creating political commitment for antimicrobial resistance in developing countries.

作者信息

Bhatia Rajesh, Katoch Vishwa Mohan, Inoue Hajime

机构信息

WHO Regional Office for South East Asia, New Delhi, India.

Indian Council of Medical Research, Department of Health Research, Ministry of Health & Family Welfare, New Delhi, India.

出版信息

Indian J Med Res. 2019 Feb;149(2):83-86. doi: 10.4103/ijmr.IJMR_1980_17.

DOI:10.4103/ijmr.IJMR_1980_17
PMID:31219072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6563734/
Abstract
摘要